Get the Stockscreener App
4.75
3.04%
0.14
After Hours:
4.76
0.010
+0.21%
Avita Medical Inc stock is traded at $4.75, with a volume of 128.23K.
It is up +3.04% in the last 24 hours and up +19.65% over the past month.
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
See More
Previous Close:
$4.61
Open:
$4.64
24h Volume:
128.23K
Relative Volume:
0.44
Market Cap:
$146.19M
Revenue:
$72.35M
Net Income/Loss:
$-45.34M
P/E Ratio:
-3.0245
EPS:
-1.5705
Net Cash Flow:
$-32.43M
1W Performance:
-7.59%
1M Performance:
+19.65%
6M Performance:
+3.94%
1Y Performance:
-17.68%
1-Day Range:
$4.60
$4.87
1-Week Range:
$4.45
$5.29
52-Week Range:
$3.22
$7.12
Avita Medical Inc Stock (RCEL) Company Profile
Name
Avita Medical Inc
Sector
Industry
Phone
661-568-1317
Address
28159 AVENUE STANFORD, VALENCIA, CA
Compare RCEL vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
4.75 | 141.88M | 72.35M | -45.34M | -32.43M | -1.5705 |
ABT
Abbott Laboratories
|
104.49 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
336.74 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
84.22 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
45.51 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.04 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-05-26 | Initiated | Northland Capital | Outperform |
| Nov-20-25 | Upgrade | BTIG Research | Sell → Neutral |
| Aug-08-25 | Downgrade | BTIG Research | Neutral → Sell |
| Dec-24-24 | Initiated | D. Boral Capital | Buy |
| Apr-11-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-27-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-02-21 | Initiated | Piper Sandler | Overweight |
| Aug-27-20 | Initiated | BofA Securities | Buy |
| Apr-21-20 | Initiated | Oppenheimer | Outperform |
| Mar-03-20 | Initiated | BTIG Research | Buy |
View All
Avita Medical Inc Stock (RCEL) Latest News
AVITA Medical Inc (RCEL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
RCEL|AVITA Medical Inc|Price:4.610| - TradingKey
AVITA Medical Inc (RCEL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AVITA Medical Inc (RCEL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
AVITA Medical Inc (RCEL) Cash Flow - TradingKey
Avita Medical Inc. (NASDAQ:RCEL) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Avita Medical (NASDAQ:RCEL) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs Revenue Breakdown – MUN:51KB - TradingView
AVITA Medical Inc (RCEL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
RCEL stock trades near recent highs as Avita Medical revenue accelerates - Ad-hoc-news.de
Avita Medical (ASX:AVH) Gains 4.00% as Commercial Expansion of Regenerative Medicine Platform Continues - Kalkine
AVITA Medical to announce Q2 2026 financial results on August 6 - scanx.trade
AVITA Medical to Announce Second Quarter 2026 Financial Results - Investing News Network
AVITA Medical Schedules Q2 Results Call for Aug. 6 Webcast - Stock Titan
AVITA Medical (RCEL) Stock Sees Fair Value Lift As Analysts Back RECELL Momentum - Yahoo Finance
AVITA Medical (ASX:AVH) Shares Drop More Than 5%: What Investors May Be Watching Next - Kalkine
Enterprise value to EBITDA forward of AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs – MUN:51KB - TradingView
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Avita Medical (RCEL) Upgraded to Buy: Here's Why - Yahoo Finance
Avita Medical Options and Restricted Stock Units Lapse Across Multiple Security Classes - Kalkine
Avita Medical Downgraded to Hold From Speculative Buy by Morgans - Moomoo
Avita Medical Reports Expiry of Over 140,000 Unquoted Securities Across Multiple Series - Kalkine Media
Avita Medical Stock Price Forecast. Should You Buy RCEL? - StockInvest.us
ASX Medical Innovation Stocks Worth Watching in July 2026 - Kalkine
TD Cowen Maintains Avita Medical(RCEL.US) With Buy Rating, Raises Target Price to $12 - Moomoo
Price to sales forward of AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs – ASX:AVH - TradingView
AVITA Medical, Inc.(NasdaqCM:RCEL) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 2500 Growth Benchmark - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 2000 Growth Benchmark - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 2000 Dynamic Index - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 3000E Index - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 2500 Index - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 3000 Index - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 2000 Index - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating AVITA Medical - The National Law Review
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 3000 Growth Benchmark - marketscreener.com
AVITA Medical Inc (RCEL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Price to book forward of AVITA Medical Inc – LS:A2P733 - TradingView
Lake Street Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Price to sales forward of Avita Medical, Inc. – NASDAQ:RCEL - TradingView
Avita Medical (RCEL) Slips to Key Support as Downside Momentum PersistsNHNL Divergence - dars.gov.et
BTIG Maintains Avita Medical(RCEL.US) With Hold Rating - Moomoo
Avita Medical (RCEL) Slips 2.73%: Testing Key Support Near $3.72Weekly Profile - dars.gov.et
AVITA Medical (RCEL) Showcases RECELL GO Clinical Data at UK Con - GuruFocus
AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting - Investing News Network
AVITA Medical’s burn treatment used in 17 U.K. patients - Stock Titan
AVITA Medical Inc (RCEL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
AVITA Medical Inc (RCEL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
AVITA Medical Inc (RCEL) Valuation: PE, PB & Fair Value Analysis - TradingKey
AVITA Medical Inc (RCEL) Institutional Confidence - TradingKey
RCEL to Host Virtual Meeting on June 23 - GuruFocus
Avita Medical Inc Stock (RCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
4.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):